These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 9395486)
1. Matrix metalloproteinase-8 is expressed in rheumatoid synovial fibroblasts and endothelial cells. Regulation by tumor necrosis factor-alpha and doxycycline. Hanemaaijer R; Sorsa T; Konttinen YT; Ding Y; Sutinen M; Visser H; van Hinsbergh VW; Helaakoski T; Kainulainen T; Rönkä H; Tschesche H; Salo T J Biol Chem; 1997 Dec; 272(50):31504-9. PubMed ID: 9395486 [TBL] [Abstract][Full Text] [Related]
2. Differential patterns of response to doxycycline and transforming growth factor beta1 in the down-regulation of collagenases in osteoarthritic and normal human chondrocytes. Shlopov BV; Smith GN; Cole AA; Hasty KA Arthritis Rheum; 1999 Apr; 42(4):719-27. PubMed ID: 10211886 [TBL] [Abstract][Full Text] [Related]
3. Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells. Effects of tumour necrosis factor alpha, interleukin 1 and phorbol ester. Hanemaaijer R; Koolwijk P; le Clercq L; de Vree WJ; van Hinsbergh VW Biochem J; 1993 Dec; 296 ( Pt 3)(Pt 3):803-9. PubMed ID: 8280080 [TBL] [Abstract][Full Text] [Related]
6. Stimulation of collagenase 3 expression in synovial fibroblasts of patients with rheumatoid arthritis by contact with a three-dimensional collagen matrix or with normal cartilage when coimplanted in NOD/SCID mice. Wernicke D; Schulze-Westhoff C; Bräuer R; Petrow P; Zacher J; Gay S; Gromnica-Ihle E Arthritis Rheum; 2002 Jan; 46(1):64-74. PubMed ID: 11817610 [TBL] [Abstract][Full Text] [Related]
7. Rheumatoid synovial endothelial cells secrete decreased levels of tissue inhibitor of MMP (TIMP1). Jackson CJ; Arkell J; Nguyen M Ann Rheum Dis; 1998 Mar; 57(3):158-61. PubMed ID: 9640131 [TBL] [Abstract][Full Text] [Related]
8. Constitutive expression of a 92-kD gelatinase (type V collagenase) by rheumatoid synovial fibroblasts and its induction in normal human fibroblasts by inflammatory cytokines. Unemori EN; Hibbs MS; Amento EP J Clin Invest; 1991 Nov; 88(5):1656-62. PubMed ID: 1658048 [TBL] [Abstract][Full Text] [Related]
10. Characterisation of the cell type-specificity of collagenase 3 mRNA expression in comparison with membrane type 1 matrix metalloproteinase and gelatinase A in the synovial membrane in rheumatoid arthritis. Petrow PK; Wernicke D; Schulze Westhoff C; Hummel KM; Bräuer R; Kriegsmann J; Gromnica-Ihle E; Gay RE; Gay S Ann Rheum Dis; 2002 May; 61(5):391-7. PubMed ID: 11959761 [TBL] [Abstract][Full Text] [Related]
12. Cell proliferation-related production of matrix metalloproteinases 1 (tissue collagenase) and 3 (stromelysin) by cultured human rheumatoid synovial fibroblasts. Hiraoka K; Sasaguri Y; Komiya S; Inoue A; Morimatsu M Biochem Int; 1992 Sep; 27(6):1083-91. PubMed ID: 1445377 [TBL] [Abstract][Full Text] [Related]
13. Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines. Mackay AR; Ballin M; Pelina MD; Farina AR; Nason AM; Hartzler JL; Thorgeirsson UP Invasion Metastasis; 1992; 12(3-4):168-84. PubMed ID: 1284126 [TBL] [Abstract][Full Text] [Related]
14. Regulation of membrane-type matrix metalloproteinase-1 expression by growth factors and phorbol 12-myristate 13-acetate. Lohi J; Lehti K; Westermarck J; Kähäri VM; Keski-Oja J Eur J Biochem; 1996 Jul; 239(2):239-47. PubMed ID: 8706726 [TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase 10 promotion of collagenolysis via procollagenase activation: implications for cartilage degradation in arthritis. Barksby HE; Milner JM; Patterson AM; Peake NJ; Hui W; Robson T; Lakey R; Middleton J; Cawston TE; Richards CD; Rowan AD Arthritis Rheum; 2006 Oct; 54(10):3244-53. PubMed ID: 17009259 [TBL] [Abstract][Full Text] [Related]
16. Effects of immortalization upon the induction of matrix metalloproteinases in rabbit synovial fibroblasts. Lin CW; Robbins PD; Georgescu HI; Evans CH Exp Cell Res; 1996 Feb; 223(1):117-26. PubMed ID: 8635483 [TBL] [Abstract][Full Text] [Related]
17. Characterization of collagenase 3 (matrix metalloproteinase 13) messenger RNA expression in the synovial membrane and synovial fibroblasts of patients with rheumatoid arthritis. Westhoff CS; Freudiger D; Petrow P; Seyfert C; Zacher J; Kriegsmann J; Pap T; Gay S; Stiehl P; Gromnica-Ihle E; Wernicke D Arthritis Rheum; 1999 Jul; 42(7):1517-27. PubMed ID: 10403281 [TBL] [Abstract][Full Text] [Related]
18. Predominant activation of MAP kinases and pro-destructive/pro-inflammatory features by TNF alpha in early-passage synovial fibroblasts via TNF receptor-1: failure of p38 inhibition to suppress matrix metalloproteinase-1 in rheumatoid arthritis. Kunisch E; Gandesiri M; Fuhrmann R; Roth A; Winter R; Kinne RW Ann Rheum Dis; 2007 Aug; 66(8):1043-51. PubMed ID: 17223661 [TBL] [Abstract][Full Text] [Related]
19. Mu-calpain is involved in the regulation of TNF-alpha-induced matrix metalloproteinase-3 release in a rheumatoid synovial cell line. Morita M; Banno Y; Dohjima T; Nozawa S; Fushimi K; Fan DG; Ohno T; Miyazawa K; Liu N; Shimizu K Biochem Biophys Res Commun; 2006 May; 343(3):937-42. PubMed ID: 16574073 [TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzymic properties. Okada Y; Morodomi T; Enghild JJ; Suzuki K; Yasui A; Nakanishi I; Salvesen G; Nagase H Eur J Biochem; 1990 Dec; 194(3):721-30. PubMed ID: 2269296 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]